[Can the occurrence of extrahepatic metastases in regional chemotherapy of the liver be prevented by adding systemic chemotherapy? A randomized multicenter study].
Hottenrott
C
C
Lorenz
M
M
D000230:Adenocarcinoma / Q000188:drug therapy / Q000401:mortality / Q000556:secondary*; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000401:mortality; D005472:Fluorouracil / Q000008:administration & dosage*; D006801:Humans; D007260:Infusion Pumps; D007261:Infusions, Intra-Arterial / Q000295:instrumentation; D007262:Infusions, Intravenous / Q000295:instrumentation; D008113:Liver Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000556:secondary*; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D011897:Random Allocation
D005472:Fluorouracil
Kann das Auftreten extrahepatischer Metastasen unter einer regionalen Chemotherapie der Leber durch eine zusätzliche systemische Chemotherapie verhindert werden? Eine randomisierte Multicenter-Studie.